Aurobindo Pharma gets approval for Perindopril Erbumine tab

16108 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

Aurobindo Pharma gets approval for Perindopril Erbumine tab

Aurobindo Pharma Limited is pleased to announce that the company has received tentative approvals from the US Food & Drug Administration for Perindopril Erbumine Tablets 2mg, 4mg, 8mg and Escitalopram Oxalate Oral solution 5mg (base) / 5ml.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Aurobindo Pharma gets US nod, stk rises 13.5% Aurobindo Ph Sept '08 qtr PAT seen at Rs 286.8 Cr: Religare Aurobindo gets approval for Didanosine Delayed Release Cap Aurobindo Pharma gets approval for Abacavir Sulfate tabs ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 25/05/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma Limited is pleased to announce that the company has received tentative approvals from the US Food & Drug Administration (USFDA) for Perindopril Erbumine Tablets 2mg, 4mg, 8mg and Escitalopram Oxalate Oral solution 5mg (base) / 5ml.

Perindopril Erbumine Tablets are the generic equivalent of Solvay Pharmaceuticals' Aceon® Tablets, falls under the CVS segment and indicated for the treatment of patients with essential hypertension.

Escitalopram Oxalate Oral solution are the generic equivalent of Forest Laboratories' Lexapro® Oral Solution, falls under the CNS segment and indicated for the treatment of major depressive disorder.

Aurobindo now has 85 approved ANDAs from the USFDA (61 Final approvals, 24 Tentative approvals) 

Sourced From: Aurobindo Pharma Limited